SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-13-291666
Filing Date
2013-07-16
Accepted
2013-07-16 14:36:52
Documents
2
Group Members
ABERDARE GP IV, L.L.C.ABERDARE PARTNERS IV, L.P.PAUL H. KLINGENSTEIN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d567318dsc13da.htm SC 13D/A 110850
2 EX-A d567318dex99a.htm EX-99.A 5056
  Complete submission text file 0001193125-13-291666.txt   117573
Mailing Address C/O ABERDARE VENTURES ONE EMBARCADERO CENTER, SUITE 4000 SAN FRANCISCO CA 94111
Business Address C/O ABERDARE VENTURES ONE EMBARCADERO CENTER, SUITE 4000 SAN FRANCISCO CA 94111 415-392-7442
ABERDARE VENTURES IV LP (Filed by) CIK: 0001433057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86488 | Film No.: 13970156
SIC: 2834 Pharmaceutical Preparations